Literature DB >> 27803841

Physician Prescribing Practices of Vitamin D in a Psychiatric Hospital.

Kimberly B Mulcahy1, Eileen Trigoboff1, Lewis Opler1, Tammie Lee Demler1.   

Abstract

Vitamin D supplementation has become an increasingly popular prescribing practice, despite our limited knowledge of both the definition and degree of deficiency as well as the expected benefits or risks of exogenous administration. Many of the hypothesized benefits of vitamin D supplementation include a variety of improvements in mental health; however, these claims are not consistently or robustly supported by current research. In this paper, we provide a brief overview of what is currently known about vitamin D deficiency and about outcomes of supplementation as well as a summary of the data relative to prescribing practices for inpatients in an urban psychiatric hospital.

Entities:  

Keywords:  Vitamin D; deficiency; depression; mood disorders; multiple sclerosis; prescribing practices; psychiatric inpatients; schizophrenia

Year:  2016        PMID: 27803841      PMCID: PMC5077255     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  23 in total

1.  Vitamin D: does it play a role in psychiatry?

Authors:  Mukesh Mohan Bhimani
Journal:  J Pak Med Assoc       Date:  2012-02       Impact factor: 0.781

2.  Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia.

Authors:  K A Graham; R S Keefe; J A Lieberman; A S Calikoglu; K M Lansing; D O Perkins
Journal:  Early Interv Psychiatry       Date:  2014-02-24       Impact factor: 2.732

3.  Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis.

Authors:  Mats B Humble; Sven Gustafsson; Susanne Bejerot
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-07       Impact factor: 4.292

4.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

5.  Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes.

Authors:  Lionel Drocourt; Jean-Claude Ourlin; Jean-Marc Pascussi; Patrick Maurel; Marie-José Vilarem
Journal:  J Biol Chem       Date:  2002-05-03       Impact factor: 5.157

6.  Vitamin D insufficiency in psychiatric inpatients.

Authors:  Melanie Rylander; Steven Verhulst
Journal:  J Psychiatr Pract       Date:  2013-07       Impact factor: 1.325

7.  Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation.

Authors:  Rabia Nazik Yüksel; Neslihan Altunsoy; Baise Tikir; Merve Cingi Külük; Kubranur Unal; Sema Goka; Cigdem Aydemir; Erol Goka
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

Review 8.  Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies.

Authors:  Ghazaleh Valipour; Parvane Saneei; Ahmad Esmaillzadeh
Journal:  J Clin Endocrinol Metab       Date:  2014-07-22       Impact factor: 5.958

9.  Serum 25-hydroxyvitamin D concentrations and depressive symptoms among young adult men and women.

Authors:  Maria A Polak; Lisa A Houghton; Anthony I Reeder; Michelle J Harper; Tamlin S Conner
Journal:  Nutrients       Date:  2014-10-28       Impact factor: 5.717

10.  Vitamin D deficiency is common in psychogeriatric patients, independent of diagnosis.

Authors:  Ole Grønli; Jan Magnus Kvamme; Rolf Jorde; Rolf Wynn
Journal:  BMC Psychiatry       Date:  2014-05-08       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.